Oncogene-dependent expression of CD44 in Balb/c 3T3 derivatives: Correlation with metastatic competence

Clinical and Experimental Metastasis

Volumn 14, Issue 1, 1996, Pages 73-82

  Kogerman, Priit ^a   Sy, Man Sun ^a   Gulp, Lloyd A ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CD44; Metastasis; Oncogene; ras; sis

Indexed keywords

HERMES ANTIGEN; HYALURONIC ACID;

ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CONTROLLED STUDY; MALIGNANT TRANSFORMATION; METASTASIS; MOUSE; NONHUMAN; ONCOGENE RAS;

EID: 0030066748     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00157688     Document Type: Article

References (25)

1. Lesley J, Hyman R and Kincade PW, 1993, CD44 and its interaction with extracellular matrix. Adv Immunol, 54, 271-335.
2. Gunthert U, Hofmann M, Rudy W, et al. 1991, A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell, 65, 13-24.
3. Sy MS, Guo YJ and Stamenkovic I, 1991, Distinct effects of two CD44 isoforms on tumor growth I'M vivo. J Exp Med, 174, 859-66.
4. Matsumura Y and Tarin D, 1992, Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet, 340, 1053-8.
5. Wielenga VJM, Heider KH, Offerhau G JA, et al. 1993, Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res, 53, 4754-6.
6. Heider K-H, Dammrich J, Skroch-Angel P, et al. 1993, Differential expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinomas and normal gastric mucosa. Cancer Res, 53, 4197-203.
7. Birch M, Mitchell S and Hart IR, 1991, Isolation and characterization of human melanoma variants expressing high and low levels of CD44. Cancer Res, 51, 6660-7.
8. Guo Y, Ma J, Wang H, et al. 1994, Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody. Cancer Res, 54, 1561-5.
9. Favrot MC, Combaret V and Lasset C, 1993, CD44 - a new prognostic marker for neuroblastoma. N Engl J Med, 329, 1965-6.
10. Gross N, Beretta C, Peruisseau G, Jackson D, Simmons D and Beck D, 1994, CD44H expression by human neuroblastoma cells: relation to MYCN amplification and lineage differentiation. Cancer Res, 54, 4238-42.
11. Pretlow TG, Nagabhusnan M, Sy MS, Guo Y and Pretlow TP, 1994, Putative preneoplastic foci in the human prostate. J Cell Biochem, Suppl. 19, 224-31.
12. Fujita N, Yaegashi N, Ide Y, et al. 1994, Expression of CD44 in normal human versus tumor endometrial tissues: possible implication of reduced expression of CD44 in lymph-vascular space involvement of cancer cells. Cancer Res, 54, 3922-8.
13. Hofmann M, Rudy W, Gunthert U, et al. 1993, A link between ras and metastatic behavior of tumor cells: ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants in CREF cells. Cancer Res, 53, 1516-21.
14. Jamal HH, Cano-Gauci DF, Buick RN and Filmus J, 1994, Activated ras and src induce CD44 overexpression in rat intestinal epithelial cells. Oncogene, 9, 417-23.
15. Lin W-C Pretlow TP, Pretlow TG and Gulp LA, 1990, Bacterial lacZ gene as a highly sensitive marker to detect micrometastasis formation during tumor progression. Cancer Res, 50, 2808-17.
16. Lin W-C, Pretlow TP, Pretlow TG and Gulp LA, 1992, High resolution analysis of two different classes of tumor cells in situ tagged with alternative marker genes. Am J Pathol, 141, 1331-42.
17. Lin W-C, O'Connor KL and Gulp LA, 1993, Complementation of two related tumor cell classes during experimental metastasis tagged with different histochemical marker genes. Br J Cancer, 67, 910-21.
18. Radinsky R, Kraemer PM, Raines MA, Kung HJ and Gulp LA, 1987, Amplification and rearrangement of the Kirsten-ras oncogene in virus-transformed Balb/c 3T3 cells during malignant tumor progression. Proc Natl Acad Sci USA. 84, 5143-7.
19. Radinsky R, Kraemer PM, Proffitt MR and Gulp LA, 1988, Clonal diversity of the Kirsten-ras oncogene during tumor progression: mechanisms of amplification and rearrangement. Cancer Res, 48, 4941-53.
20. Radinsky R and Gulp LA, 1991, Clonal dominance of select subsets of viral Kirsten-ras transformed 3T3 cells during tumor progression. Int J Cancer, 48, 148-59.
21. Miyake K, Medina KL, Hayashi SI, Ono S, Hamaoka T and Kincade PW, 1990, Monoclonal antibodies to Pgp-l/CD44 block lympho-hemopoiesis in long-term bone marrow cultures. J Exp Med, 171, 477-88.
22. Miyake K, Underbill CB, Lesley J and Kincade PW, 1990, Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J Exp Med, 172, 69-75.
23. Laemmli U, 1970, Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680-5.
24. Guo Y, Ma J, Wang JH, et al. 1993, Hyaluronic acid and anti-CD44 antibodies have distinct effects on the activation of murine T-cell hybridomas and normal T-lymphocytes. Cell Immunol, 152, 186-99.
25. Sambrook J, Fritsch EF and Maniatis T, 1989, Molecular Cloning: a Laboratory Manual. 2nd edn. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, vol. 1-3.